United States Diagnostics Market Report 2021-2026: Patient Protection & Affordable Care Act, Medicare and Medicaid to Positively Influence the Market

Dublin, July 09, 2021 (GLOBE NEWSWIRE) -- The "United States Diagnostics Market, By Product Type (Reagents, Instruments, Software & Services), By Type of Test (Infectious Disease Testing, Lipid Panel, Others), By Technique, By Usability, By Application, By End User, By Region, Competition Forecast & Opportunities, 2026" report has been added to ResearchAndMarkets.com's offering.

The United States Diagnostics Market stood at USD30.08billion in 2020 and is expected to grow at a steady rate of 5.17% during the forecast period.

The United States Diagnostics Market is driven by the growing prevalence of various chronic and infectious diseases. Additionally, increasing awareness among the population pertaining to healthcare is further expected to propel the market growth. Besides, supportive government policies & schemes such as Patient Protection & Affordable Care Act, Medicare and Medicaid are further expected to positively influence the market growth through 2026.

Furthermore, increasing investment on R&D and new product or instruments/techniques launches by the major players is expected to create lucrative opportunities for the market growth over the next few years. Moreover, the sudden outbreak and spread of pandemic COVID-19 within the country has drastically increased the demand for infectious disease testing diagnostic tests and procedures being carried out. It has also increased the demand for rapid test kits which can help in the diagnosis of disease, thereby fueling the market growth.

The United States Diagnostics Market is segmented based on product type, type of test, technique, usability, application, end-user, company and region. Based on product type, the market can be categorized into reagents, instruments and software & services. Among these, the reagents segment dominated the market in 2020 with a share of around 54.35%.

This is expected to continue its dominance over the forecast period as well. This can be attributed to the fact that reagents form an integral part of a diagnostic procedure or test, and no laboratory-based diagnostic procedure or test can be performed without the use of reagents. Additionally, the growing demand for rapid and accurate diagnostics is further expected to fuel the segmental growth.

Furthermore, an increase in demand for self-testing and point-of-care testing is expected to spur the growth of reagents. Besides, increasing research & development pertaining to reagents is expected to create lucrative opportunities for the market growth. The software & service segment is expected to hold a significant market share owing to the growing preference for accurate, reliable and efficient diagnostic software.

Regionally, the market can be categorized into North-East, Mid-West, West and South. Among these, the Southern region in the United States is expected to dominate the overall diagnostics market with a share of around 33.86% in 2020 and is expected to continue maintaining its dominance over the forecast period as well.

This can be attributed to the high population density, growing industrialization and increasing establishment of industries and factories in the region. This in turn increases the susceptibility of the population to various chronic and infectious diseases especially respiratory problems, thereby driving the market growth in the region.

Companies are developing advanced technologies and launching new products to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new product developments.

Companies Mentioned

• Abbott Laboratories, Inc.

• Danaher Corporation

• Thermo Fisher Scientific, Inc.

• Johnson & Johnson

• Ortho-Clinical Diagnostics, Inc.

• Becton, Dickinson, and Company

• Bio-Rad Laboratories, Inc.

• Roche Diagnostics Corporation

• Siemens Medical Solutions USA, Inc.

• Biomerieux Inc.

Years considered for this report:

• Historical Years: 2016-2019

• Base Year: 2020

• Estimated Year: 2021

• Forecast Period: 2022-2026

Report Scope:

United States Diagnostics Market, By Product Type:

• Reagents

• Instruments

• Software & Services

United States Diagnostics Market, By Type of Test:

• Infectious Disease Testing

• Lipid Panel

• Metabolic Panel

• Others

United States Diagnostics Market, By Technique:

• Immunodiagnostics

• Clinical Techniques

• Molecular Diagnostics

• Tissue Diagnostics

• Others

United States Diagnostics Market, By Usability:

• Reusable

• Disposable

United States Diagnostics Market, By Application:

• Infectious Diseases

• Human Papillomavirus

• Hepatitis

• Tuberculosis

• Hospital-Acquired Infections

• COVID-19

• Cancer

• Breast Cancer

• Lung Cancer

• Colorectal Cancer

• Melanoma

• Liver Cancer

• Others

• Sexually Transmitted Diseases

• Chlamydia Trachomatis Infection

• Gonorrhoea

• Syphilis

• Others

United States Diagnostics Market, By End-User:

• Hospitals & Clinics

• Diagnostic Centers

• Point-of-Care Testing Centers

• Private or Commercial Laboratories

• Others

For more information about this report visit https://www.researchandmarkets.com/r/kxlug6

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900